id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-D-0548-0011,FDA,FDA-2021-D-0548,"Data Standards for Drug and BiologicalProduct Submissions Containing Real-
World Data; Draft Guidance for Industry; Availability; Extension of Comment Period",Notice,Extension of Comment Period,2021-12-21T05:00:00Z,2021,12,2021-12-21T05:00:00Z,2022-02-05T04:59:59Z,2022-02-05T02:00:49Z,2021-27521,0,0,0900006484ed8389
FDA-2021-D-0548-0005,FDA,FDA-2021-D-0548,Request to Extension from Pharmaceutical Research and Manufacturers of America (PhRMA),Other,Request for Extension,2021-11-05T04:00:00Z,2021,11,2021-11-05T04:00:00Z,,2021-11-05T20:15:36Z,,0,0,0900006484e25b86
FDA-2021-D-0548-0001,FDA,FDA-2021-D-0548,Data Standards for Drug and Biological Product Submissions Containing Real-World Data; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2021-10-22T04:00:00Z,2021,10,2021-10-22T04:00:00Z,2021-12-22T04:59:59Z,2021-12-22T02:00:13Z,2021-23081,0,0,0900006484de265d
FDA-2021-D-0548-0002,FDA,FDA-2021-D-0548,"Data Standards for Drug and Biological Product Submissions Containing Real-World Data
Guidance for Industry",Other,Guidance,2021-10-22T04:00:00Z,2021,10,2021-10-22T04:00:00Z,2022-02-05T04:59:59Z,2023-12-22T15:07:01Z,,0,0,0900006484de3a83